Aspira Pathlab & Diagnostics: Promoter Jay Arvind Bhanushali Acquires Additional Shares
Aspira Pathlab & Diagnostics Ltd 路 Acquisition/ Disposal of Shares 路 12 Sept 2026, 6:50 pm
Aspira Pathlab & Diagnostics: Promoter Jay Arvind Bhanushali Acquires Additional Shares Promoter Jay Arvind Bhanushali disclosed an open-market acquisition of 74 equity shares (0.00% voting capital) in Aspira Pathlab & Diagnostics Ltd on 10th Sep'26. Following the transaction, Bhanushali's total shareholding marginally increased from 7,46,377 equity shares to 7,46,451 equity shares, while the total voting share capital remained steady at 7.25%. The company's total equity share capital stands at Rs 10,29,30,000, divided into 1,02,93,000 equity shares of Rs 10 each.
Original exchange filing (PDF)
More announcements from Aspira Pathlab & Diagnostics Ltd
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jay Arvind Bhanushali 路 14 Nov 2026
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jay Arvind Bhanushali 路 14 Nov 2026
- Enclosed herewith Financial Result for the Half Year ended 30th September 2026 路 06 Nov 2026
- Enclosed herewith Board Meeting Outcomes dated 6th November 2026 路 06 Nov 2026
- Aspira Pathlab & Diagnostics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/11/2026 ,inter alia, to consider and approve Un-audited Financial .... 路 06 Nov 2026
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jay Arvind Bhanushali 路 01 Oct 2026
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jay Arvind Bhanushali 路 28 Sept 2026
- Disclosure of Voting Results of 53rd Annual General Meeting along with the Scrutinizer Report 路 26 Sept 2026
